

Dabigatran Etexilate (150mg)
10 capsules in 1 strip
Cash on delivery available
Afogatran 150 Capsule is an oral anticoagulant medication containing the active ingredient apixaban, a highly selective inhibitor of factor Xa, a key enzyme involved in the blood clotting cascade. Each capsule delivers a fixed dose of apixaban, providing consistent and predictable anticoagulation therapy. Afogatran 150 Capsule is indicated for various clinical conditions requiring anticoagulation, including stroke prevention in atrial fibrillation (AF) and treatment of venous thromboembolism (VTE).
Afogatran 150 Capsule is primarily used for the following purposes:
The key benefit of Afogatran 150 Capsule lies in its potent anticoagulant action combined with a reduced risk of bleeding complications compared to traditional anticoagulants such as warfarin. By selectively inhibiting factor Xa, Afogatran 150 Capsule prevents the formation of harmful blood clots while minimizing the risk of bleeding events, offering effective protection against thromboembolic events with improved safety profile.
While Afogatran 150 Capsule is generally well-tolerated, some individuals may experience mild to moderate side effects. Potential side effects may include:
It is essential to promptly report any unusual or persistent side effects to a healthcare professional.
Follow these guidelines for proper usage of Afogatran 150 Capsule:
Afogatran 150 Capsule works by selectively inhibiting factor Xa, a key enzyme involved in the coagulation cascade. By blocking factor Xa, apixaban interferes with the formation of thrombin, a crucial step in the blood clotting process. This prevents the conversion of fibrinogen to fibrin and inhibits the formation of stable blood clots in the veins and arteries.
Unlike traditional anticoagulants such as warfarin, which inhibit multiple clotting factors and require frequent monitoring, Afogatran 150 Capsule offers targeted inhibition of factor Xa with fixed dosing and minimal monitoring requirements. This makes Afogatran 150 Capsule an attractive option for patients requiring long-term anticoagulant therapy, offering effective protection against thromboembolic events while minimizing the risk of bleeding complications.
In summary, Afogatran 150 Capsule is a valuable medication for the prevention of stroke, venous thromboembolism, and other cardiovascular events in high-risk patients. With its selective factor Xa inhibition and convenient oral administration, Afogatran 150 Capsule provides effective anticoagulant therapy with predictable dosing and minimal monitoring requirements. However, it is essential to use Afogatran 150 Capsule as directed and promptly report any adverse reactions or bleeding events to a healthcare professional.
Cash on delivery available